University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Blagden, S"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 3.

Article

Coley, HM, Hatzimichael, E, Blagden, S, McNeish, I, Thompson, A, Crook, T and Syed, N (2012) Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. Oncotarget, 3 (1). pp. 78-83.

Syed, N, Coley, HM, Sehouli, J, Koensgen, D, Mustea, A, Szlosarek, P, McNeish, I, Blagden, SP, Schmid, P and Lovell, DP (2011) Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer. Cancer Res, 71 (9). pp. 3317-3327.

Conference or Workshop Item

Gungor, H, Saleem, A, Agarwal, R, Blagden, S, Michael, A, Stronach, EA, Chen, M, Pickford, E, Rama, NR, Lewis, YL, Carme, SC, Salinas, C, Smith, DA, Krachey, E, Santiago-Walker, A, Gunn, RN, El-Bahrawy, M, Babar,, SA, Morris, R and Gabra, H Pharmacokinetic (PK)/pharmacodynamic (PD) analysis of escalating repeat doses of the AKT inhibitor GSK2141795 (GSK795) in patients (pts) with ovarian cancer. In: ASCO, 2011-06-03 - 2011-06-07, Chicago USA.

This list was generated on Thu Sep 21 16:14:41 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800